748 related articles for article (PubMed ID: 17169097)
1. Successful treatment with topical tacrolimus in four cases of discoid lupus erythematosus.
Sugano M; Shintani Y; Kobayashi K; Sakakibara N; Isomura I; Morita A
J Dermatol; 2006 Dec; 33(12):887-91. PubMed ID: 17169097
[TBL] [Abstract][Full Text] [Related]
2. Pimecrolimus 1% cream versus betamethasone 17-valerate 0.1% cream in the treatment of facial discoid lupus erythematosus: a double-blind, randomized pilot study.
Barikbin B; Givrad S; Yousefi M; Eskandari F
Clin Exp Dermatol; 2009 Oct; 34(7):776-80. PubMed ID: 19456797
[TBL] [Abstract][Full Text] [Related]
3. Pimecrolimus 1% cream for cutaneous lupus erythematosus.
Kreuter A; Gambichler T; Breuckmann F; Pawlak FM; Stücker M; Bader A; Altmeyer P; Freitag M
J Am Acad Dermatol; 2004 Sep; 51(3):407-10. PubMed ID: 15337984
[TBL] [Abstract][Full Text] [Related]
4. Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative.
Lampropoulos CE; Sangle S; Harrison P; Hughes GR; D'Cruz DP
Rheumatology (Oxford); 2004 Nov; 43(11):1383-5. PubMed ID: 15266063
[TBL] [Abstract][Full Text] [Related]
5. Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis.
Yoshimasu T; Ohtani T; Sakamoto T; Oshima A; Furukawa F
Eur J Dermatol; 2002; 12(1):50-2. PubMed ID: 11809595
[TBL] [Abstract][Full Text] [Related]
6. Pimecrolimus 1% cream for the treatment of discoid lupus erythematosus.
Tlacuilo-Parra A; Guevara-Gutiérrez E; Gutiérrez-Murillo F; Soto-Ortiz A; Barba-Gómez F; Hernández-Torres M; Salazar-Páramo M
Rheumatology (Oxford); 2005 Dec; 44(12):1564-8. PubMed ID: 16159951
[TBL] [Abstract][Full Text] [Related]
7. A comparative study in efficacy and safety of 0.1% tacrolimus and 0.05% clobetasol propionate ointment in discoid lupus erythematosus by modified cutaneous lupus erythematosus disease area and severity index.
Pothinamthong P; Janjumratsang P
J Med Assoc Thai; 2012 Jul; 95(7):933-40. PubMed ID: 22919989
[TBL] [Abstract][Full Text] [Related]
8. Topical 0.1% tacrolimus for the treatment of discoid lupus erythematosus and pemphigus erythematosus in dogs.
Griffies JD; Mendelsohn CL; Rosenkrantz WS; Muse R; Boord MJ; Griffin CE
J Am Anim Hosp Assoc; 2004; 40(1):29-41. PubMed ID: 14736903
[TBL] [Abstract][Full Text] [Related]
9. 0.1% tacrolimus ointment in the treatment of discoid lupus erythematosus.
Heffernan MP; Nelson MM; Smith DI; Chung JH
Arch Dermatol; 2005 Sep; 141(9):1170-1. PubMed ID: 16172325
[No Abstract] [Full Text] [Related]
10. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.
Doss N; Reitamo S; Dubertret L; Fekete GL; Kamoun MR; Lahfa M; Ortonne JP
Br J Dermatol; 2009 Aug; 161(2):427-34. PubMed ID: 19416227
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Scarring Alopecia in Discoid Variant of Chronic Cutaneous Lupus Erythematosus With Tacrolimus Lotion, 0.3.
Milam EC; Ramachandran S; Franks AG
JAMA Dermatol; 2015 Oct; 151(10):1113-6. PubMed ID: 26039539
[TBL] [Abstract][Full Text] [Related]
12. The effect of topical tacrolimus on severe recalcitrant chronic discoid lupus erythematosus.
Walker SL; Kirby B; Chalmers RJ
Br J Dermatol; 2002 Aug; 147(2):405-6. PubMed ID: 12174136
[No Abstract] [Full Text] [Related]
13. Efficacy of topical tacrolimus in the treatment of various cutaneous manifestations of lupus erythematosus.
von Pelchrzim R; Schmook T; Friedrich M; Worm M
Int J Dermatol; 2006 Jan; 45(1):84-5. PubMed ID: 16426386
[No Abstract] [Full Text] [Related]
14. Tacrolimus 0.03% ointment in labial discoid lupus erythematosus: A randomized, controlled clinical trial.
Wang X; Zhang L; Luo J; Wu Z; Mei Y; Wang Y; Li X; Wang W; Zhou H
J Clin Pharmacol; 2015 Nov; 55(11):1221-8. PubMed ID: 25951426
[TBL] [Abstract][Full Text] [Related]
15. Comparison of cutaneous tolerance and efficacy of calcitriol 3 microg g(-1) ointment and tacrolimus 0.3 mg g(-1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial.
Liao YH; Chiu HC; Tseng YS; Tsai TF
Br J Dermatol; 2007 Nov; 157(5):1005-12. PubMed ID: 17935517
[TBL] [Abstract][Full Text] [Related]
16. Linear childhood discoid lupus erythematosus following the lines of Blaschko: successfully treated with topical tacrolimus.
Kawachi Y; Taguchi S; Fujisawa Y; Furuta J; Nakamura Y; Ishii Y; Otsuka F
Pediatr Dermatol; 2011; 28(2):205-7. PubMed ID: 20825568
[TBL] [Abstract][Full Text] [Related]
17. Granuloma faciale successfully treated with topical tacrolimus.
Patterson C; Coutts I
Australas J Dermatol; 2009 Aug; 50(3):217-9. PubMed ID: 19659988
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus ointment for the treatment of severe facial plaque psoriasis.
Kroft EB; Erceg A; Maimets K; Vissers W; van der Valk PG; van de Kerkhof PC
J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):249-51. PubMed ID: 15752305
[TBL] [Abstract][Full Text] [Related]
19. Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial.
Radakovic S; Breier-Maly J; Konschitzky R; Kittler H; Sator P; Hoenigsmann H; Tanew A
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):951-3. PubMed ID: 19496898
[TBL] [Abstract][Full Text] [Related]
20. The use of topical calcineurin inhibitors in lupus erythematosus: an overview.
Wollina U; Hansel G
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):1-6. PubMed ID: 18005117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
